This policy brief considers state telehealth laws as they govern the use of telehealth for ADHD or Tourette syndrome diagnosis, monitoring, or treatment. The policy brief summarizes the legal landscape and evidence and offers a research agenda and policy options for future consideration. It contributes toward a more holistic understanding of how laws act as facilitators or barriers to supports and treatment for children with neurodevelopmental conditions.
The brief was published alongside the Pediatric ADHD Medication Prior Authorization Policies in Medicaid Managed Care Plans dataset. It is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,249,998.00 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.